Nephros (NEPH) Asset Writedowns and Impairment (2015 - 2026)
Nephros (NEPH) posted quarterly Asset Writedowns and Impairment of $11000.0 for Q1 2026, up 83.33% year-over-year from $6000.0 in Q1 2025, and down 8.33% quarter-over-quarter from $12000.0 in Q4 2025.
Nephros (NEPH) Asset Writedowns and Impairment (2015 - 2026) Analysis & Trends
Nephros' Asset Writedowns and Impairment history runs 12 years deep, the most recent figure standing at $11000.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment rose 83.33% year-over-year to $11000.0; the TTM figure through Mar 2026 stood at $73000.0 (down 62.56% YoY), while the FY2025 annual figure was $68000.0, down 74.05% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $11000.0, down from $12000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $1.3 million in Q3 2022, with the low at $6000.0 in Q1 2025.
- The 5-year median for Asset Writedowns and Impairment is $48000.0 (2024), against an average of $135400.0.
- The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment jumped 1396.51% in 2022, then plunged 91.78% in 2025.
- Nephros' Asset Writedowns and Impairment stood at $1.3 million in 2022, then sank by 85.31% to $189000.0 in 2023, then slumped by 74.6% to $48000.0 in 2024, then slumped by 75.0% to $12000.0 in 2025, then fell by 8.33% to $11000.0 in 2026.
- Business Quant data shows NEPH's Asset Writedowns and Impairment at $11000.0 in Q1 2026, $12000.0 in Q4 2025, and $15000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,000.00 |
| Jun 30, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Mar 31, 2024 | 73,000.00 |